Investor profile for IndieBio: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.
SOSV's pioneering biotech accelerator and pre-seed fund in San Francisco, backing scientist-founders in human and planetary health; SOSV rebranded the IndieBio program to SOSV SF and SOSV NY in early 2026 while continuing the same deep-tech investing mandate.
Keep track of IndieBio
Save this profile to your VCT watchlist for a quick return.
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Source link not recordedConfidence: 25%Verified: Not recordedView methodology
Investment stages
Leads: Pre-Seed, Seed
Participates: Pre-Seed, Seed
Sector focus
Biotech & Life Sciences · Climate Tech
Geography
San Francisco, CA
Founded 2014
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
None yet
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Pre-Seed
Seed
Rounds they invest
Pre-Seed
Seed
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates
are not presented as firm disclosures.
FAQs about IndieBio
Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.
Per our directory, IndieBio leads pre-seed and seed rounds. Historically it ran a four-month accelerator with on-site bio labs plus initial investment for scientist-founders launching their first companies.
IndieBio/SOSV has not published a fixed check size for 2026. Our directory classifies it as pre-seed and seed only; founders should consult sosv.com for current program terms rather than assuming a standard venture check.
IndieBio originated in San Francisco and SOSV also operated a New York program. SOSV invests globally across its accelerator network; IndieBio's 310+ alumni companies have raised capital internationally, not only in the Bay Area.
Our directory tags biotech-life-sciences and climate-tech. IndieBio's public track record spans therapeutics, diagnostics, food and agriculture, industrial decarbonization, and AI applied to biology—human and planetary health at the core.
IndieBio typically leads or provides the first institutional capital through its accelerator investment, then companies raise larger seed and Series A rounds with financial VCs. It is a program-first investor, not a passive follower.
We do not currently have startups in our directory with IndieBio listed as an investor. IndieBio reports 310+ graduate companies (2015–2025) that raised about $3.6B collectively—many are not yet profiled on Venture Capital Tracker.
Scientists with a startup concept should apply through SOSV's accelerator application process at sosv.com. IndieBio's site notes the program name changed to SOSV SF and SOSV NY in early 2026; the teams and facilities continue under the SOSV brand.
We do not yet have a dedicated IndieBio article. For context on SOSV's broader health and climate investing, see our industry hubs for biotech-life-sciences and climate-tech, and watch for future SOSV program coverage.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
